| Market Cap | 2.05M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -3.1M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -9.00% |
| Sales | 1.93M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -51.00% |
| Dividend | N/A | Price/Book | 0.15 | EPS next 5Y | - | 52W High Chg | -91.00% |
| Recommedations | - | Quick Ratio | 1.51 | Shares Outstanding | 3.48M | 52W Low Chg | 14.00% |
| Insider Own | 6.47% | ROA | -4.97% | Shares Float | 3.47M | Beta | 1.13 |
| Inst Own | 2.11% | ROE | -21.65% | Shares Shorted/Prior | 455.33K/40.57K | Price | 0.20 |
| Gross Margin | 28.73% | Profit Margin | -160.67% | Avg. Volume | 512,527 | Target Price | - |
| Oper. Margin | 733.81% | Earnings Date | - | Volume | 247,763 | Change | 1.98% |
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
